Analysis Alnylam’s Monopoly Math Gets a Reality Check
For nearly eight years, Alnylam has enjoyed something almost unheard of in biotech: a drug with no true rival for a fatal heart condition. That exclusivity has been the foundation...
Top Stories
Latest financial market updates and expert analysis
Analysis 
AI & Quantum Computing
Amazon’s $220 Billion Infrastructure Bet: The Market Just Changed Its Verdict
AI & Quantum Computing
View All
Defense & Aerospace
View All
Cryptocurrency
View All
Banking & Finance
View All
Latest News
Commodities
Almonty Industries Tightens Its Trading Footprint as Tungsten Stock Battles a Volatile Stretch
The tungsten producer’s journey toward a leaner exchange structure is nearly complete. Almonty Industries has now secured approval to delist...
Earnings
Micron’s $1,100 Peak Fades as Investors Weigh a Fully Booked Future Against a Volatile Present
The arithmetic is jarring. Micron Technology closed Friday at 714.70 euros, down 5.86 percent on the day and 21.71 percent...
DAX
SAP’s Comeback Bid Faces Its Sternest Test: Can Cloud Growth Outweigh the Cost of Two Acquisitions?
The numbers tell a story of a company inching back from the edge. SAP’s shares closed Friday at €159.40, up...
Commodities
Vulcan Energy’s Cash Burn Accelerates Even as Lionheart’s Financial Backbone Falls Into Place
The numbers tell a story of two very different timelines. On one hand, Vulcan Energy has just sealed the financial...
Earnings
Novo Nordisk’s August Reckoning: A Failed Heart Drug, a Depressed Valuation, and Earnings That Could Go Either Way
The options market is bracing for fireworks. When Novo Nordisk delivers its second-quarter results on August 5, derivatives pricing implies...
Analysis
AST SpaceMobile’s August Launch Window Opens With Valuation Debate in Full Swing
The countdown to AST SpaceMobile’s next orbital mission is drawing to a close, and the stakes extend well beyond the...
Analysis
Bloom Energy’s Split Personality: Record Fundamentals Wrestling With a 42% Drawdown
The arithmetic at Bloom Energy is genuinely strange right now. The fuel-cell maker just posted the strongest quarter in its...
Commodities
Highland Critical Minerals: A Slimmed-Down Explorer Waits on Summer Data to Break Its Trading Range
The story of Highland Critical Minerals right now is one of patience. After a corporate overhaul that stripped the company...
Automotive & E-Mobility
SpaceX Stock Teeters at 52-Week Low as First Earnings, Lock-Up Expiry and Merger Denial Collide
The timing could hardly be more precarious. SpaceX shares closed Friday at €93.96, down 3.48 percent in a single session,...
Analysis
Bayer’s Two-Front Legal Strategy: From Defendant to Plaintiff While Awaiting a Landmark Ruling
The company that spent years in American courtrooms as the defendant is now turning the tables. Bayer has filed patent...